Price (delayed)
$0.1784
Market cap
$40.53M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.1
Enterprise value
$12.23M
Ampio Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company primarily engaged in the development of AmpionTM, its lead anti-inflammatory drug, which is currently undergoing clinical trials focused on the treatment
There are no recent dividends present for AMPE.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.